Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

XPhyto Therapeutics: Are they Selling the Solution to Germany’s Rapid Testing Crisis?

The Germans call it COVID-19 “rapid testing mania”. But like most manias, it has opened up a Pandora’s box of problems. As the speed of the vaccine rollout program falters in Europe, on-the-spot antigen testing continues to be the ...
Marc Davis | June 2, 2021 |

XPhyto: Why Rapid PCR Testing is Here to Stay

Regular coronavirus testing is destined to become the norm for many years to come, regardless of how many people get vaccinated against COVID-19. So says Hugh Rogers, the CEO of XPhyto Therapeutics Corp. ( CSE: XPHY ) (FSE: 4XT) ( OTC: XPHYF ) , a Canadian life scie...
Marc Davis | April 22, 2021 |

XPhyto: Buyouts, Biosensors and a Booming Business

Test, test, test! It’s the World Health Organization’s battle cry in the global war against COVID-19 and other coronaviruses – including future outbreaks. And it is not getting any less resonant as new variants continue to cause ha...
Marc Davis | August 3, 2021 |

Buzz on the Bullboards: The Fastest Moving Up & Comers

In recent days, weeks, even months, markets on both sides of the 49 th parallel have been erratic as volatility has returned with a vengeance. Investors continue to gather at Stockhouse. What is a buying opportunity for one investor is a "selling window" for another. ...
Stockhouse Editorial | September 29, 2021 |

Strong Historical Probability of NG Long Trades Setting Up

Would you believe that March and April, historically, shows a 2 to 1 statistical probability of NG moving higher. Each of these months shows, historically, that NG has a strong potential for at least a $1.00 upside price move in both March and April. Only 1/3 of the historical...
Chris Vermeulen | March 8, 2019 |

FDA Approves First-of-Its-Kind, Adult Pneumonia Antibiotic; September Launch Planned

The drug's features and its developer's commercial plans are discussed in an H.C. Wainwright & Co. report. In an Aug. 20 research note, analyst Ed Arce reported that H.C. Wainwright & Co. raised its target price on Nabriva Therapeutics Plc (NBRV:NASDAQ) to $8 per sh...
Streetwise Reports | August 28, 2019 |

Catching Up with the Company that’s Crafting the New Standard In Cannabis Extracts

When we last caught up with Adastra Labs Holdings Ltd. ( CSE.XTRX , OTC: XTXXF , Forum ) and their CEO Michael Forbes back in December , our Stockhouse audience got an in-depth look at one of the most innovative leaders in cannabis science. Stockhouse Media&CloseCu...
Dave Jackson | March 30, 2022 |

Buzz on the Bullboards: 2021’s Highlights

2021 was another year of ups, downs, and everything in between, but it was also a year marked by continued global economic uncertainty and a shakeup of some of the hottest investment sectors. I took notice when I realized how often I had been updating my template...
Stockhouse Editorial | December 15, 2021 |

Standard Lithium Successfully Commissioned Demonstration Plant Despite COVID-19

The Critical Investor takes a look at the current dynamics of the lithium market, and speaks with the Standard Lithium's CEO about the firm's latest news. LiSTR demonstration plant at Lanxess project site After Standard Lithium Ltd. (SLL:TSX.V; ST...
Streetwise Reports | June 15, 2020 |

Best Precious Metals Investment and Trade Setups for 2019

It’s been years since the gold and silver topped out in 2011. We have been waiting for a new bottom form and a new bull market to emerge for nearly 8 years. In this article, I’m going to compare palladium, gold, platinum, and silver and show you...
Chris Vermeulen | March 18, 2019 |
1 2 3 4 5 6 7 8 9 10 ...